SCHISTOACT: a protocol for an open-label, five-arm, non-inferiority, individually randomized controlled trial of the efficacy and safety of praziquantel plus artemisinin-based combinations in the treatment of Schistosoma mansoni infection

BACKGROUND: Schistosomiasis control relies on praziquantel for preventive chemotherapy. Alternative drugs are needed for the treatment and control of schistosomiasis. Praziquantel is effective against adult schistosome worms but ineffective against larval stages of the parasite and cannot prevent re...

Descripción completa

Detalles Bibliográficos
Autores principales: Obonyo, Charles O., Were, Vincent O., Wamae, Peter, Muok, Erick M. O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683197/
https://www.ncbi.nlm.nih.gov/pubmed/38012787
http://dx.doi.org/10.1186/s13063-023-07790-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10683197/
https://www.ncbi.nlm.nih.gov/pubmed/38012787
http://dx.doi.org/10.1186/s13063-023-07790-3

Ejemplares similares